The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

Aubagio: The New Pill Approved for Multiple Sclerosis (MS)

by Dr. Sharon Orrange on October 10, 2012 at 1:25 pm

Many have been waiting for a pill for MS, and here it is. Injectables (Avonex, Betaseron, Copaxone and Rebif) are currently the mainstay of treatment for MS, so realize that most MS patients are currently injecting themselves once daily or once a week. Now, there may be a pill option. This month the Food and Drug Administration (FDA) announced the approval of Aubagio (teriflunomide), a once-daily tablet for the treatment of multiple sclerosis.

Aubagio is an immunomodulator with anti-inflammatory properties. Although the exact mechanism of action for Aubagio is not fully understood, it helps reduce the number of lymphocytes (white blood cells) in the central nervous system.

Aubagio is approved for patients with the relapsing form of MS; these are patients who have flare-ups and then have almost complete recovery. Aubagio was approved because of promising studies that showed the use of Aubagio significantly reduced the relapse rate in MS patients and the time to disability progression.

So it’s a pill, not a shot, and what is also really great is that in these MS studies on Aubagio, the incidence of serious side effects was similar among Aubagio and placebo-treated patients.

Great news!

Dr O.

Aubagio is now available now from some pharmacies, in 7 mg and 14 mg strengths. It runs about $3750 for a one-month supply, and if covered by insurance, it will likely fall under Tier 2 or 3, meaning a moderate to highly monthly copay.

Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.